FDA chief: Personalized medicine will spur industry collaborations

11/11/2008 | Philadelphia Inquirer, The

Major medical advances and scientific discoveries will bring together drugmakers, small biotech firms and medical-device manufacturers to develop more personalized treatments for patients with cancer and other life-threatening diseases, according to FDA chief Dr. Andrew von Eschenbach. These developments also could change the way companies test treatments and force the FDA to overhaul its drug-review process, von Eschenbach said.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC